作者
Nathalie Daaboul, Melina Boutin, Catherine Sperlich, Margit Fuchs, Louis-Patrick Haraoui, Giovanna Speranza, Nghia T Trung Nguyen, Flavia De Angelis, Samuel Martel, Sara V Soldera, Sabrina Trudel, Pierre Desjardins, Line Srour, Benoit Samson, Susan Fox, Celine Devaux, Catherine Prady
发表日期
2022/6/1
来源
Journal of Clinical Oncology
卷号
40
期号
16_suppl
页码范围
e24043-e24043
出版商
American Society of Clinical Oncology
简介
e24043
Background: Concerns about safety and treatment interference are known barriers to COVID-19 vaccination in cancer patients. Data on safety and tolerability in this population remain scarce. One of the objectives of this study is to describe COVID-19 vaccination safety in cancer patients. Methods: Patients diagnosed with a malignancy requiring systemic treatment in the last 12 months and undergoing COVID-19 vaccination were prospectively enrolled in this single-center study. Validated questionnaires to assess vaccine-related adverse events (VRAEs) were collected; chart review identified baseline characteristics and treatments received. Descriptive statistics and logistic regressions were performed. Results: 253 questionnaires were collected from 171 patients, enrolled between May and September 2021. 130 patients were survey-eligible after the 1st dose (D1) and 185 after 2nd dose (D2). 91 …
学术搜索中的文章
N Daaboul, M Boutin, C Sperlich, M Fuchs, LP Haraoui… - 2022